20
Southwest Synthetic Pharmaceutical Corporation, Limited Chongqing Cn, based in China, is a pharmaceutical company.
One of their significant offerings is Trimethoprim, supported by a 'Withdrawn by EDQM Failure to CEP procedure' Certificate of Suitability (CEP) with the number R1-CEP 1997-009 - Rev 05
This Chemical Type CEP, issued on December 08, 2015, remains in force until May 21, 2021, ensuring its reliability within the pharmaceutical industry.
Substance Number 60 associated with this CEP further emphasizes